Modern Retina Spring 2022

A multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.

In the face of the COVID-19 pandemic, the procedure required adjustments.

The implant achieves impressive efficacy and reduces treatment burden.

Investigational pipeline provides promise for an unmet need.

The first FDA-approved bispecific antibody for the eye targets two leading causes of vision loss.